Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Patel Snehal | CEO and CFO | Mar 22 '24 | Buy | 19.98 | 2,500 | 49,950 | 5,347,777 | Mar 26 06:05 AM | Patel Snehal | CEO and CFO | Mar 20 '24 | Buy | 17.68 | 1,500 | 26,520 | 5,345,277 | Mar 22 06:02 AM | Patel Snehal | CEO and CFO | Mar 05 '24 | Buy | 12.49 | 30,500 | 380,945 | 5,343,777 | Mar 07 06:05 AM | Patel Snehal | CEO and CFO | Mar 04 '24 | Buy | 13.03 | 4,100 | 53,423 | 5,340,277 | Mar 06 06:05 AM | Patel Snehal | CEO and CFO | Feb 16 '24 | Buy | 11.16 | 10,800 | 120,528 | 5,336,177 | Feb 21 06:05 AM | Patel Snehal | CEO and CFO | Feb 15 '24 | Buy | 11.07 | 12,700 | 140,589 | 5,325,377 | Feb 20 06:04 AM | Patel Snehal | CEO and CFO | Nov 10 '23 | Buy | 10.17 | 5,000 | 50,838 | 5,312,677 | Nov 14 06:05 AM | Patel Snehal | CEO and CFO | Nov 03 '23 | Buy | 9.11 | 3,500 | 31,885 | 5,307,677 | Nov 07 06:15 AM | Thompson Jaye | VP Clinical Reg Affairs | Oct 27 '23 | Buy | 8.57 | 500 | 4,285 | 260,348 | Oct 31 06:16 AM | Patel Snehal | CEO and CFO | Oct 26 '23 | Buy | 7.97 | 2,500 | 19,925 | 5,304,177 | Oct 30 06:15 AM | Patel Snehal | CEO and CFO | Oct 25 '23 | Buy | 7.91 | 2,500 | 19,775 | 5,301,677 | Oct 27 06:15 AM | Patel Snehal | CEO and CFO | Oct 10 '23 | Buy | 9.07 | 1,000 | 9,070 | 5,299,177 | Oct 12 06:05 AM | Patel Snehal | CEO and CFO | Oct 04 '23 | Buy | 8.63 | 2,000 | 17,260 | 5,298,177 | Oct 05 06:05 AM | Thompson Jaye | VP Clinical Reg Affairs | Sep 26 '23 | Buy | 8.71 | 600 | 5,226 | 259,848 | Sep 28 06:05 AM | Patel Snehal | CEO and CFO | Sep 19 '23 | Buy | 8.95 | 4,000 | 35,800 | 5,296,177 | Sep 21 06:05 AM | Patel Snehal | CEO and CFO | Sep 11 '23 | Buy | 9.48 | 1,000 | 9,480 | 5,292,177 | Sep 13 06:05 AM | Patel Snehal | CEO and CFO | Aug 22 '23 | Buy | 9.97 | 1,000 | 9,970 | 5,291,177 | Aug 24 06:05 AM | Patel Snehal | CEO and CFO | Aug 04 '23 | Buy | 10.55 | 2,000 | 21,100 | 5,290,177 | Aug 08 06:05 AM | Patel Snehal | CEO and CFO | Jul 21 '23 | Buy | 9.20 | 1,000 | 9,200 | 5,288,177 | Jul 25 06:15 AM | Thompson Jaye | VP Clinical Reg Affairs | Jul 13 '23 | Buy | 9.49 | 250 | 2,372 | 259,248 | Jul 17 06:15 AM | Patel Snehal | CEO and CFO | May 17 '23 | Buy | 11.69 | 1,000 | 11,690 | 5,287,177 | May 18 06:01 AM | Thompson Jaye | VP Clinical Reg Affairs | Apr 28 '23 | Buy | 11.22 | 250 | 2,805 | 258,998 | May 02 06:06 AM | Patel Snehal | CEO and CFO | Apr 19 '23 | Buy | 11.10 | 7,000 | 77,700 | 5,286,177 | Apr 21 06:05 AM | Patel Snehal | CEO and CFO | Apr 18 '23 | Buy | 11.12 | 2,000 | 22,240 | 5,279,177 | Apr 20 06:05 AM | Patel Snehal | CEO and CFO | Apr 11 '23 | Buy | 12.42 | 5,000 | 62,100 | 5,271,177 | Apr 12 06:02 AM | Thompson Jaye | VP Clinical Reg Affairs | Apr 11 '23 | Buy | 11.87 | 1,000 | 11,870 | 258,745 | Apr 12 06:05 AM |
|